TerminatedNot Applicable

A Long-term Follow-up Study of Patients Who Received VOR33

Stopped: Lack of Funding

United States10 participantsStarted 2022-04-15

Plain-language summary

VOR33 long-term follow-up (LTFU) study

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Has received any part of or all of a VOR33 infusion

What they're measuring

Long term safety of VOR33 in patients who participated in a VOR33 study in terms of study product-related Adverse Events/Serious Adverse Events (AEs/SAEs).

Timeframe: Years 1-15

Trial details

NCT IDNCT05309733

SponsorVor Biopharma

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-05-28

View on ClinicalTrials.gov More Leukemia, Myeloid, Acute trials